Inhaled Nitric Oxide Delivery Device Market
Inhaled Nitric Oxide Delivery Device Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Inhaled Nitric Oxide Delivery Device Market Size and Growth
The Inhaled Nitric Oxide Delivery Device market is experiencing significant growth, driven by rising respiratory disorders and increased adoption in healthcare settings. The market size is projected to reach approximately $300 million by 2025, influenced by advancements in technology and expanding applications, particularly in neonatal and adult critical care sectors. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Mallinckrodt Pharmaceuticals
◍ Getinge
◍ Vero Biotech
◍ LINDE
◍ Beyond Air
◍ Air Liquide Healthcare
◍ Circassia Pharmaceuticals
◍ NU MED
◍ Bellerophon Therapeutics
◍ Praxair Technology Inc.
The Inhaled Nitric Oxide Delivery Device Market features companies like Mallinckrodt, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, and Circassia. These firms innovate delivery technologies, enhance patient outcomes, and expand market access, driving growth. Notable sales include Mallinckrodt ($1.4B in 2022) and Air Liquide (€23.5B in 2022).
Request Sample Report
